ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.92bn
- $2.21bn
- $883.37m
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
ANI Pharma rises after J.P.Morgan initiates coverage with 'overweight' rating
HubSpot rises after Barclays upgrades to 'overweight' on AI capabilities
Brief: ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
U.S. STOCKS ON THE MOVE-BridgeBio Pharma, NetApp, Talen Energy
U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines
ANI Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
ANI Pharma rises as rare-disease drugs drive quarterly results beat
U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva Systems
ANI Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: ANI Pharmaceuticals Q3 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.09
U.S. RESEARCH ROUNDUP- ANI Pharmaceuticals, Deere & Co, Zoetis
Brief: ANI Pharmaceuticals Announces The FDA Approval And Launch Of Ketoconazole Shampoo
U.S. STOCKS ON THE MOVE- Teladoc Health, Veritex, New York Community Bancorp
U.S. STOCKS ON THE MOVE- AppLovin, Regal Rexnord, Talkspace
Guggenheim raises PT on ANI Pharma after Alimera deal completion
U.S. STOCKS ON THE MOVE-GE Vernova, Dell, Super Micro Computer
U.S. STOCKS ON THE MOVE-Intel, ANI Pharmaceuticals, New York Community Bancorp
Guggenheim raises PT on ANI Pharma after Alimera deal completion